Patent details

EP3936130 Title: VALBENAZINE DOSAGE REGIMEN FOR THE TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS

Basic Information

Publication number:
EP3936130
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP211788823
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
VALBENAZINE DOSAGE REGIMEN FOR THE TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS
French Title of Invention:
RÉGIME POSOLOGIQUE DE VALBÉNAZINE POUR LE TRAITEMENT DES TROUBLES DE MOUVEMENT HYPERKINÉTIQUE
German Title of Invention:
DOSIERUNGSSCHEMA FÜR VALBENAZIN ZUR BEHANDLUNG VON HYPERKINETISCHEN BEWEGUNGSSTÖRUNGEN
SPC Number:

Dates

Filing date:
06/05/2015
Grant date:
14/02/2024
EP Publication Date:
12/01/2022
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/02/2024
EP B1 Publication Date:
14/02/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/05/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/11/2025
 
 

Name:
NEUROCRINE BIOSCIENCES, INC.
Address:
6027 Edgewood Bend Court,, CA 92130, San Diego, United States (US)

History of Owners

From:
07/02/2024
To:
20/11/2025

Name:
Neurocrine Biosciences, Inc.
Address:
12780 El Camino Real, San Diego, California 92130, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
22/03/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
O'BRIEN, Christopher
Address:
United States (US)

Priority

Priority Number:
201461989240 P
Priority Date:
06/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/473; A61P 25/00; A61P 25/14; A61P 43/00;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2025/13
Publication date:
04/12/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
202407
Publication date:
14/02/2024
Description:
Grant (B1)

2

Issue number:
202412
Publication date:
20/03/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20250000437A
Date Registered:
20/11/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
NEUROCRINE BIOSCIENCES, INC.
Address:
6027 Edgewood Bend Court,, CA 92130, San Diego, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/05/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
22/03/2024 Power Of Attorney 1
22/03/2024 Outgoing Correspondence 1
20/11/2025 Request For Change 1
20/11/2025 Outgoing Correspondence 2